HomeAI · summaries
Storia in 2 fonti
Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
It’s been seven years since Pfizer scored an expansion for its breast cancer blockbuster Ibrance, and during that time, the drug has started to lag sales of two others in its class—Eli Lilly’s Verz | It’s been seven years since Pfizer scored an expansion for its blockbuster Ibrance. But it finally happened Wednesday with a nod as a maintenance therapy in HR+/HER2+ breast cancer.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercebiotech.com
A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s onc | Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics…
- ·
fiercepharma.com
Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
It’s been seven years since Pfizer scored an expansion for its breast cancer blockbuster Ibrance, and during that time, the drug has started to lag sales of two others in its…